FDECX
Price
$25.22
Change
-$0.07 (-0.28%)
Updated
Jun 2 closing price
Net Assets
6.36B
VVIAX
Price
$83.17
Change
+$0.71 (+0.86%)
Updated
Jun 2 closing price
Net Assets
237.83B
Interact to see
Advertisement

FDECX vs VVIAX

Header iconFDECX vs VVIAX Comparison
Open Charts FDECX vs VVIAXBanner chart's image
FDECX vs VVIAX Comparison Chart in %
View a ticker or compare two or three
VS
FDECX vs. VVIAX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDECX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 238B vs. FDECX (6.36B). VVIAX pays higher dividends than FDECX: VVIAX (1.87) vs FDECX (0.26). FDECX was incepted earlier than VVIAX: FDECX (21 years) vs VVIAX (26 years). FDECX (1.66) is less costly to investors than VVIAX (0.05). FDECX is a more actively managed with annual turnover of: 18.00 vs. VVIAX (8.00). FDECX has a lower initial minimum investment than VVIAX: FDECX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 23.22 vs. FDECX (17.37). VVIAX return over 5 years is better than : 50.68 vs. FDECX (45.37).
FDECXVVIAXFDECX / VVIAX
Total Expense Ratio1.660.053,320%
Annual Report Gross Expense Ratio1.660.053,320%
Fund Existence21 years26 years-
Gain YTD9.67010.67091%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.36B238B3%
Annual Yield % from dividends0.261.8714%
Returns for 1 year17.3723.2275%
Returns for 3 years53.1953.18100%
Returns for 5 years45.3750.6890%
Returns for 10 years106.66150.4271%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLFS27.490.86
+3.21%
BioLife Solutions
PBR18.72-0.14
-0.74%
Petroleo Brasileiro Sa-Petrobras ADS (REP 1 Common Share)
ZNTL3.95-0.03
-0.75%
Zentalis Pharmaceuticals
CELU1.05-0.02
-1.87%
Celularity
PTCT68.23-5.57
-7.55%
PTC Therapeutics